VWF and hemorrhagic disease: Risk factors include reduced mobility related to joint bleeds [55,56]; however, the bleeding disorder itself may contribute through a reduction in FVIII-VWF-mediated inhibition of receptor activator of nuclear factor κB (RANK) ligand-induced osteoclastogenesis [18,57].